Q1 2023 Vistin Pharma ASA Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Vistin Pharma Quarterly Report Q1 2023 Conference Call. (Operator Instructions).
I would now like to hand the conference over to your speaker today, Kjell-Erik Nordby, CEO. Please go ahead, sir.
()
Thank you very much. Welcome to this webcast presenting the first quarter 2023 results in Vistin Pharma. Now we start with the highlights for the quarter. We had a record high revenue in the quarter above NOK 100 million in revenue versus NOK 33 million in the first quarter last year. This significant increase in revenue is due to the fact that we are now producing material from both production lines, and that has resulted in more volumes available for sale compared to the 8-week production stop that we had in the first quarter last year when we did the MEP installation.
This record high revenue also has resulted in a high EBITDA for the quarter compared to the negative EBITDA on -- in first quarter
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
